ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be "World's Lightest"

Nov.12.2024
ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be "World's Lightest"
ISMOD launches new HTP products in the US market, available on brand's website and vapesourcing, catering to e-cigarette users.

Special Disclaimer:

  • This article is for industry communication purposes only and does not endorse any brand or product.
  • The images displayed in this article are for factual description only and are not advertisements for any product.
  • This article is restricted to minors.

 

Recently, 2Firsts noticed that the heated tobacco brand ISMOD has launched two new HTP products in the US market—the ISMOD Mini Tobacco Heating Device and the ISMOD Jet Tobacco Heating Device. These products are now available on the ISMOD official website and the US e-cigarette distributor site, Vapesourcing.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
ISMOD Mini | Image source: ISMOD official website

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
ISMOD Jet | Image source: ISMOD official website

 

 Specifically, the product features of the ISMOD Mini and ISMOD Jet are as follows:

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Product specifications of ISMOD Mini and ISMOD Jet | Illustration: 2Firsts

 

According to the distributor website Vapesourcing, the ISMOD Mini is described as the "lightest HNB device in the world."

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
ISMOD Mini is the "lightest HNB device in the world" | Image source: vapesourcing

 

In addition, both the ISMOD Mini and ISMOD Jet are marked as "best used with BUDDZ tobacco sticks." The BUDDZ official website also features a heated tobacco device, the BUDDZ DEVICE, which closely resembles the ISMOD Mini in terms of design and specifications.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Translation: BUDDZ DEVICE | Image source: BUDDZ official website

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Translation into English: BUDDZ DEVICE|Image source: BUDDZ official website.

 

As early as the tobacco exhibition held in Dortmund this September, 2Firsts had already noticed the ISMOD brand and its products. The ISMOD II PLUS, in particular, became the brand's main highlight at the exhibition, featuring a battery device combined with two tobacco stick heating devices.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Translation: Dortmund Tobacco Exhibition ISMOD Booth | Image Source: 2Firsts

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
ISMOD II PLUS | Image Source: ISMOD

 

It is worth noting that the ISMOD Mini and ISMOD Jet were previously only available on the official ISMOD websites for regions such as Europe, the UK, and Jordan. Their launch on the US e-cigarette distributor site Vapesourcing makes them the only two HTP products currently listed on the site.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Heating tobacco devices displayed on the vapesourcing website | Image source: vapesourcing

 

The ISMOD official website shows that the brand is owned by ISMOD UK Ltd., a registered company in England and Wales with registration number 13047166. The company's registered address is in the Westminster district of the UK, and its business address is on Greenlands Avenue in London.

 

ISMOD Launches Two Heated Tobacco Devices in the US, ISMOD Mini Claims to Be
Company information displayed on the ISMOD brand official website | Image source: ISMOD official website

 

2Firsts will continue to monitor the latest products and market trends in the heated tobacco sector, providing the public with accurate and authoritative industry information.

 


 

2Firsts' product column remains committed to delivering readers the latest product updates in the new tobacco field. We invite readers to submit insights and news on e-cigarette developments.

 

For unique perspectives or information, feel free to contact us at carrie.cai@2firsts.com or scan the QR code below.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
A new expert paper in JAMA urges U.S. clinicians to include nicotine e-cigarettes in smoking-cessation discussions, citing higher quit rates than nicotine replacement therapy. It also stresses that products must deliver enough nicotine to replace cigarettes, dual use should be brief, and complete switching is the goal. 2Firsts argues the recommendations matter beyond clinics: public-health professionals should reassess relative risk, regulators should preserve sufficient product appeal for adult smokers, and manufacturers should focus on helping users quit cigarettes more sustainably.
SCIENCE
Aug.03 by 2Firsts Perspectives
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
Multiple JTI-backed studies in the UK and Ireland indicate that illicit tobacco remains visible across consumer interactions and local markets. In the UK, JTI research found that 31% of respondents said they had been offered illicit tobacco products. In Ireland’s Ennis area, a JTI-commissioned empty pack survey found that 63% of sampled cigarette packs did not carry Irish duty-paid markings. The findings come from industry research rather than official government estimates of illicit tobacco market size, but highlight continued concerns among regulators, legitimate retailers and tobacco companies over illicit trade.
Aug.19
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10
Product | DOJO Launches 0+6ml BLAST7K Fresh in UK in September, Retaining 2+8ml Pod Compatibility Ahead of October Per-Milliliter Vaping Duty
Product | DOJO Launches 0+6ml BLAST7K Fresh in UK in September, Retaining 2+8ml Pod Compatibility Ahead of October Per-Milliliter Vaping Duty
DOJO officially launched the BLAST7K Fresh on September 17, 2026, introducing a UK-market prefilled pod product with 6ml of e-liquid and a manufacturer-rated capacity of up to 7,000 puffs. The device features a 1000mAh rechargeable battery, the INSTA-JUICED structure and COREX BLAST dual-mesh technology, while retaining compatibility with existing BLAST pods. The launch comes less than two weeks before the UK's Vaping Products Duty takes effect on October 1. At the new duty rate, 6ml of vaping liquid would correspond to £1.32 in VPD. DOJO has not stated that the product's 6ml format was designed in response to the new duty.
Sep.20